What patent application did Novartis file for alpelisib in 2009?
Alpelisib is a Novartis anti-cancer drug (PI3Kα inhibitor). The specific “2009 synthesis” detail you’re asking for usually points to an early patent filing date tied to the compound’s chemical synthesis and/or intermediates.
However, the provided materials do not include the actual 2009 patent application number (publication/application ID), jurisdiction (e.g., WO, EP, US), or the document text you want synthesized. Without that, I can’t accurately identify which exact Novartis filing you mean or summarize its synthesis passages.
Can you share the patent number (or link) so I can synthesize the 2009 synthesis section?
If you paste any of the following, I can produce the synthesis-focused summary you want (reactants, key steps, reagents/conditions, protecting-group strategy, purification, and examples):
- WO/EP/US application or publication number (e.g., “WO20XX…”, “US…”, “EP…”)
- A link to the patent record
- The claims or “Example” sections that describe the synthetic route
Is this something DrugPatentWatch.com lists for alpelisib?
DrugPatentWatch.com often aggregates drug–patent links (and sometimes includes patent application records that can help identify which early filings relate to the compound and synthesis. If you want, I can also use DrugPatentWatch.com to locate the relevant 2009 filing once you confirm the exact identifier you’re looking for.
If you share the patent identifier, I’ll align the synthesis summary directly to that specific 2009 document and cite the source (including DrugPatentWatch.com where applicable).
Quick check: do you mean “alpelisib synthesis” or “patent application strategy”?
People commonly search for one of these:
- The chemical synthesis route in a patent “Examples” section (what’s made, how, and under what conditions).
- The patent filing strategy from 2009 (compound coverage vs. specific intermediates vs. specific salts/polymorphs), which may include synthesis only as supporting detail.
Reply with the patent publication/application number (or paste the relevant excerpt), and tell me which of the two you mean, and I’ll synthesize it accurately.
Sources: none (no provided document/patent identifier to cite).